Home » Drug Information » Recently Approved Drugs » 1998
Medical Areas: Cardiology/Vascular Diseases | Endocrinology
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Novartis
Approval Status: Approved March 1998
Treatment Area: second-line treatment of hypertension
Diovan HCT has been approved for second-line treatment of
hypertension. Diovan HCT is a combination of an angiotensin II
receptor blocker (ARB)--a first line treatment that lowers blood
pressure with an overall incidence of side effects comparable to
placebo--and a diuretic, which is commonly used with other
therapies to provide additional blood pressure lowering.
